ACI Archean Chemical Industries Q1 FY26 results (Apr–Jun 2025) and concall
Archean Chemical reported a strong Q1 FY26 with consolidated revenue growing 30% YoY to ₹300.59 crores, driven by stable volumes in Bromine and Industrial Salt. While standalone EBITDA grew 13% YoY, consolidated net profit was impacted by initial losses from subsidiaries. The company is making progress on strategic initiatives like SOP commercialization and Oren Hydrocarbon's revival, with sales expected from Q3 FY26, and remains net debt-free.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|
| Revenue | 238 | 243 | 322 | 279 |
| EBITDA | 76 | 84 | 90 | 83 |
| Net profit | 22 | 56 | 58 | 52 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
